Introduction {#S0001}
============

Autophagy is a cellular mechanism that enables recycling of cytoplasmic contents and plays an important role in cellular homeostasis \[[1](#CIT0001),[2](#CIT0002)\]. Macroautophagy/autophagy is initiated with the formation of the phagophore, a double-membrane structure that surrounds a portion of cytoplasm \[[3](#CIT0003)\]. These structures progress to the development of autophagosomes that fuse with lysosomes to form autolysosomes that release nutrients to the cytoplasm \[[3](#CIT0003)\]. A major regulator of autophagy is established to be the MTOR (mechanistic target of rapamycin kinase) pathway that can sense cellular energy and amino acid levels \[[4](#CIT0004)\]. TORC1 (target of rapamycin complex 1) is activated when cells are in a nutrient rich environment, which leads to inhibition of autophagy \[[4](#CIT0004)\]. However, suppression of TORC1 activity in response to low energy balance or amino acid starvation causes increased autophagy \[[4](#CIT0004)\].

It was recently reported that MAPK8/JNK1 (mitogen-activated protein kinase 8), but not MAPK9/JNK2 (mitogen-activated protein kinase 9), is required for the induction of autophagy by starvation \[[5](#CIT0005)\]. This mechanism of MAPK8 signaling is mediated by BCL2 (B cell leukemia/lymphoma 2) phosphorylation (on Thr69, Ser70, and Ser87) that disrupts the interaction of BCL2 with BECN1 (beclin 1, autophagy related) and initiates BECN1-dependent autophagy \[[5](#CIT0005)\]. Subsequent studies have provided strong support for this role of MAPK8 in autophagy \[[6](#CIT0006)--[19](#CIT0019)\], although contributing roles for MAPK9 \[[20](#CIT0020)--[23](#CIT0023)\] and alternative potential functions of MAPK8 related to autophagy have also been reported \[[24](#CIT0024)--[29](#CIT0029)\].

The MAPK8-promoted autophagy pathway raises several questions. First, what is the mechanistic relationship between the MAPK8 and MTOR pathways in the regulation of autophagy by starvation? Second, since MAPK8 exhibits functional redundancy as a BCL2 kinase \[[20](#CIT0020),[30](#CIT0030)--[34](#CIT0034)\], what mechanism accounts for the requirement of MAPK8 for starvation-induced autophagy? The purpose of this study was to examine these two questions in the context of starvation-induced autophagy. We show that the role of MAPK8/9 in autophagy may be context-dependent and substantially more complex than previously considered.

Results {#S0002}
=======

MTOR-regulated autophagy does not require MAPK8/9 {#S0002-S2001}
-------------------------------------------------

It is established that MTOR is a master regulator of starvation-induced autophagy \[[4](#CIT0004)\]. The requirement of MAPK8 for starvation-induced autophagy \[[5](#CIT0005)\] may therefore reflect a role for MAPK8 upstream or down-stream of MTOR. Indeed, previous studies have demonstrated that MAPK8/9 can be activated in response to TORC1 signaling \[[35](#CIT0035)\] and that TORC1 activation can require MAPK8/9 signaling \[[28](#CIT0028)\]. Alternatively, MAPK8/9 and TORC1 may function in parallel pathways that control autophagy.

To test whether MAPK8/9 plays a role in autophagy induction downstream of MTOR, we examined the effect of torin 1, a small molecule inhibitor of MTOR. Control studies demonstrated that torin 1 prevented the phosphorylation of the MTOR substrate RPS6KB1/p70 (ribosomal protein S6 kinase, polypeptide 1) on Thr389 in both wild-type (WT) and *mapk8^−/-^ mapk9^−/-^* immortalized mouse embryonic fibroblasts (MEFs) (Figure. 1(a) and S1A). To assess the effect of torin 1 on autophagy, we initially examined the formation of MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3 beta) puncta in the cytoplasm by fluorescence microscopy. We found that torin 1 caused LC3B puncta in both WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs ([Figure 1(b)](#F0001)). This observation suggested that MAPK8/9 deficiency caused no major change in autophagy as a result of MTOR inhibition. This conclusion was confirmed by measurement of autophagic flux by monitoring the formation of phosphatidylethanolamine-conjugated LC3B-II in response to MTOR inhibition in the presence of a lysosomal inhibitor \[[36](#CIT0036)\] ([Figure. 1(c)](#F0001) and S1B) and reduced accumulation of the autophagic substrate SQSTM1/p62 (sequestosome 1) ([Figure. 1(d)](#F0001) and S1C).10.1080/15548627.2018.1466013-F0001Figure 1.Autophagy caused by MTOR inhibition does not require MAPK8/9 in immortalized MEFs. (a) The amount of RPS6KB1, p-Thr389 RPS6KB1, and TUBA (tubulin alpha) in WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation without or with 250 nM torin 1 (2 or 4 h) was examined by immunoblot analysis. (b) WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs were transduced with a lentivirus vector that expresses GFP-LC3B. Puncta formation following incubation of the cells with 250 nM torin 1 (2 and 4 h) was examined by fluorescence microscopy. Scale bar: 30 µm. (c) LC3B and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) expression by WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation (2 h) without or with 250 nM torin 1 in the absence or presence of 25 µM chloroquine (CQ) was examined by immunoblot analysis. The LC3B-II:GAPDH ratios were normalized to the mean of WT control condition (first lane). The 'Change in MAP1LC3B-II' was calculated by subtracting MAP1LC3B-II:GAPDH (media+ CQ condition) from MAP1LC3B-II:GAPDH (torin 1+ CQ condition). The data presented represent the mean ± SEM; n = 3 independent experiments; \*, *p *\< 0.05; \*\*, *p *\< 0.01; \*\*\*, *p *\< 0.001; \*\*\*\*, *p *\< 0.0001. Two-way ANOVA was used for the analysis of LC3B-II expression and Student's *t*-test is used for the flux analysis. (d) The amount of SQSTM1 and TUBA in WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation with 250 nM torin 1 (2 or 4 h) was examined by immunoblot analysis. The SQSTM1:TUBA ratio was quantified and normalized to SQSTM1 expression in WT cells treated without torin 1 (mean ± SEM; n = 3 independent experiments; \*\*, *p *\< 0.01 (two-way ANOVA). (e) RPS6KB1, p-Thr389 RPS6KB1, AKT, p-Thr308 AKT, p-Ser473 AKT, and GAPDH expression by WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation (2 or 4 h) without or with 200 nM rapamycin was examined by immunoblot analysis. (f) LC3B and TUBA expression by WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation (2 h) without or with 200 nM rapamycin in the presence or absence of 25 µM chloroquine (CQ) was examined by immunoblot analysis. The LC3B-II:TUBA ratios were normalized to the mean of WT control (first lane). The data presented represent the mean ± SEM; n = 3 independent experiments; \*, *p *\< 0.05; \*\*, *p *\< 0.01; \*\*\*, *p *\< 0.001. Two-way ANOVA was used for the analysis of LC3B-II expression and Student's *t*-test was used for the flux analysis.

Torin 1 is an active site-directed inhibitor of MTOR and therefore inhibits both MTOR complexes TORC1 and TORC2 (target of rapamycin complex 2) \[[37](#CIT0037)\]. To test the role of TORC1, we used a low dose of rapamycin to selectively block TORC1 \[[37](#CIT0037)\]. Control studies demonstrated that rapamycin inhibited phosphorylation of the TORC1 substrate RPS6KB1 at Thr389, but not the TORC2 substrate AKT (thymoma viral proto-oncogene) at target site Ser473 ([Figure 1(e)](#F0001)). We found that treatment of WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs with rapamycin caused a similar increase in autophagic flux that was measured by monitoring the accumulation of LC3B-II in the presence of a lysosomal inhibitor \[[36](#CIT0036)\] ([Figure. 1(f)](#F0001) and S1D).

Collectively, these data demonstrate that MAPK8/9 are not required for autophagy induced in response to inhibition of TORC1 (by rapamycin) or inhibition of TORC1 and TORC2 (by torin 1).

Starvation-induced autophagy does not require MAPK8/9 {#S0002-S2002}
-----------------------------------------------------

Our analysis of the effects of MTOR on autophagy in immortalized MEFs demonstrated that MAPK8/9 does not regulate autophagy downstream of MTOR ([Figure 1](#F0001)). It was therefore possible that MAPK8/9 functions upstream of MTOR in the regulation of autophagy by starvation \[[28](#CIT0028)\]. To test this hypothesis, we examined TORC1 signaling in response to starvation. We found that starvation prevented the phosphorylation of the TORC1 substrate RPS6KB1 at Thr389 in both WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs (Figure. 2(a) and S2A). MAPK8/9 are therefore not required for suppression of TORC1 signaling by starvation. Studies of autophagy demonstrated similar LC3B puncta formation following starvation of WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs ([Figure 2(b)](#F0002)). Similarly, no differences in autophagic flux ([Figure. 2(c)](#F0002) and S2B) or accumulation of the autophagic substrate SQSTM1 ([Figure. 2(d)](#F0002) and S2C) were detected between WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs. This analysis suggests that MAPK8/9 in immortalized MEFs play no required role in starvation-induced autophagy.10.1080/15548627.2018.1466013-F0002Figure 2.Autophagy caused by starvation does not require MAPK8/9 in immortalized MEFs. (a) RPS6KB1, p-Thr389 RPS6KB1, and TUBA expression by WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation with EBSS containing 5mM glucose (2 or 4 h) was examined by immunoblot analysis. (b) WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs were transduced with a lentivirus vector that expresses GFP-LC3B. Puncta formation following incubation with EBSS containing 5 mM glucose (2 h) was examined by fluorescence microscopy. Scale bar: 30 µm. (c) LC3B and GAPDH in WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation (2 h) in medium or with EBSS containing 5 mM glucose in the presence or absence of 25 µM chloroquine (CQ) was examined by immunoblot analysis. The LC3B-II:GAPDH ratios were normalized to the average of WT control condition (first lane). The data presented represent the mean ± SEM; n = 3 independent experiments; \*, *p *\< 0.05; \*\*, *p *\< 0.01; \*\*\*; *p *\< 0.001; \*\*\*\*; *p *\< 0.0001. Two-way ANOVA was used for the analysis of LC3B-II expression and Student's *t*-test was used for the flux analysis. (d) The amount of SQSTM1 and GAPDH in WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs after incubation with EBSS containing 5 mM glucose (2 or 4 h) was examined by immunoblot analysis. The SQSTM1:GAPDH ratio was quantified and normalized to WT cells treated without EBSS (mean ± SEM; n = 3 independent experiments); \*, *p *\< 0.05; \*\*, *p *\< 0.01; \*\*\*; *p *\< 0.001 (two-way ANOVA).

MAPK8/9 activation and MTOR inhibition {#S0002-S2003}
--------------------------------------

Our inability to detect a difference in autophagy between WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs was not anticipated. One explanation for this finding is that MAPK8/9 are not regulated under the conditions that we employed for these experiments. Indeed, we found that MTOR inhibition caused by starvation (Figure. 3(a) and S3A) or treatment with torin 1 ([Figure. 3(b)](#F0003) and S3B) under the conditions of the autophagy assays did not lead to MAPK8/9 activation. It is therefore possible that in a different cell type, or under different culture conditions, MAPK8/9 could be activated and thus may contribute to the regulation of autophagy during starvation or torin 1 treatment.10.1080/15548627.2018.1466013-F0003Figure 3.Effect of starvation and MTOR inhibition on MAPK8/9 activation is not sufficient to cause autophagy. (a and b) MAPK8/9 activation in immortalized MEFs was examined by immunoblot analysis of p-Thr183/Tyr185 MAPK8/9, MAPK8/9, and GAPDH in cells after incubation (2 or 4 h) with EBSS containing 5 mM glucose (a) or 250 nM torin 1 (b). Lanes 1 and 2 represent positive and negative controls: lysates of WT MEFs exposed to 60 J/m^2^ UV and *mapk8^−/-^ mapk9^−/-^* MEFs, respectively. (c) WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs were exposed to UV radiation (60 J/m^2^) and cell extracts were prepared at 45 min post-irradiation. The expression of LC3B, p-Thr183/Tyr185 MAPK8/9, MAPK8/9, and GAPDH was examined by immunoblot analysis.

To test whether MAPK8/9 activation is sufficient for the induction of autophagy, we examined the effect of MAPK8/9 activation on the conversion of LC3B-I to LC3B-II by immunoblot analysis using WT and *mapk8^−/-^ mapk9^−/-^* immortalized MEFs. We found that activated MAPK8/9 caused no change in LC3B-II formation ([Figure. 3(c)](#F0003) and S3C). These data suggest that MAPK8/9 activation is not sufficient for autophagy and that MAPK8/9-promoted autophagy likely involves interactions between MAPK8/9 and other pro-autophagic signaling pathways.

MAPK8/9 is not required for starvation or torin 1-induced autophagy in primary MEFs {#S0002-S2004}
-----------------------------------------------------------------------------------

Our initial studies of immortalized MEFs may be compromised by the loss of TRP53 (transforming related protein 53) function in these cells, which may change autophagic responses \[[38](#CIT0038)\]. We therefore repeated our studies using early passage primary WT and *mapk8^−/-^ mapk9^−/-^* MEFs (Figure 4(a)). The primary MEFs exhibited reduced autophagy flux compared with immortalized MEFs. We found that MAPK8/9 deficiency caused no change in LC3B puncta formation in response to starvation ([Figure 4(b)](#F0004)). Similarly, MAPK8/9-deficiency caused no change in starvation-induced autophagic flux ([Figure. 4(c)](#F0004) and S4A) or accumulation of the autophagic substrate SQSTM1 ([Figure. 4(d)](#F0004) and S4B). Control studies demonstrated that starvation under these conditions did not activate MAPK8/9 ([Figure 4(e)](#F0004)), but did prevent phosphorylation of the TORC1 substrate RPS6KB1 at Thr389 ([Figure. 4(f)](#F0004) and S4C).10.1080/15548627.2018.1466013-F0004Figure 4.Autophagy caused by starvation does not require MAPK8/9 in primary MEFs. (a) (Z)-4-Hydroxytamoxifen-treated primary *Rosa-*Cre*^ERT^* (WT) MEFs and *Rosa-*Cre*^ERT^ Mapk8^LoxP/LoxP^ mapk9^−/-^* MEFs were examined by immunoblot analysis by probing with antibodies to MAPK8/9 and TUBA. (b) WT and *mapk8^−/-^ mapk9^−/-^* primary MEFs were transduced with a lentivirus vector that expresses GFP-LC3B. Puncta formation following incubation with EBSS containing 5 mM glucose (2 and 4 h) was examined by fluorescence microscopy. Scale bar: 25 µm. (c) LC3B and GAPDH expression by WT and *mapk8^−/-^ mapk9^−/-^* primary MEFs after incubation (2 h) in medium or with EBSS containing 5 mM glucose in the presence or absence of 25 µM chloroquine (CQ) was examined by immunoblot analysis. The LC3B-II:GAPDH ratios were normalized to the mean of WT control (first lane). The data presented represent the mean ± SEM; n = 3 independent experiments; \*, *p *\< 0.05. Two-way ANOVA was used for the analysis of LC3B-II expression and Student's *t-*test was used for the flux analysis. (d) The amount of SQSTM1 and TUBA in WT and *mapk8^−/-^ mapk9^−/-^* primary MEFs after incubation with EBSS containing 5 mM glucose (2 h) was examined by immunoblot analysis. The SQSTM1:TUBA ratio was quantified and normalized to SQSTM1 expression in WT non-starved cells (mean ± SEM; n = 3 independent experiments). (e) MAPK8/9 activation in WT and *mapk8^−/-^ mapk9^−/-^* primary MEFs was examined by immunoblot analysis of p-Thr183/Tyr185 MAPK8/9, MAPK8/9, and GAPDH after incubation (2 h) with media or EBSS containing 5 mM glucose. WT MEFs exposed to UV (60 J/m^2^) and *mapk8^−/-^ mapk9^−/-^* represent positive and negative controls. (f) RPS6KB1, p-Thr389 RPS6KB1, and TUBA in WT and *mapk8^−/-^ mapk9^−/-^* primary MEFs after incubation (2 h) with EBSS containing 5 mM glucose was examined by immunoblot analysis.

Studies of torin 1-induced autophagy demonstrated similar inhibition of the phosphorylation of the TORC1 substrate RPS6KB1 at Thr389 in primary WT and *mapk8^−/-^ mapk9^−/-^* MEFs (Figure S5A) and similar torin 1-induced LC3B puncta formation (Fig. S5B). A small decrease in autophagic flux (Fig. S5C) and modestly increased accumulation of the autophagic substrate SQSTM1 (Fig. S5D) was detected in *mapk8^−/-^ mapk9^−/-^* primary MEFs compared with WT primary MEFs.

Together, these data indicate that MAPK8/9 play no required role in starvation-induced autophagy in primary MEFs.

Requirement of MAPK8 and MAPK9 for starvation-induced autophagy in primary MEFs {#S0002-S2005}
-------------------------------------------------------------------------------

It is possible that our analysis of compound MAPK8/9-deficiency in MEFs is compromised by compensatory mechanisms that are engaged in these cells. Indeed, the role of MAPK8/9 in starvation-induced autophagy was first established in studies using *mapk8^−/-^* and *mapk9^−/-^* primary MEFs \[[5](#CIT0005)\]. We therefore examined the effects of starvation on WT, *mapk8^−/-^*, and *mapk9^−/-^* primary MEFs. Starvation prevented the phosphorylation of the TORC1 substrate RPS6KB1 at Thr389 in these cells (Fig. S6A). Studies of WT, *mapk8^−/-^*, and *mapk9^−/-^* primary MEFs identified similar LC3B puncta formation (Fig. S6B), accumulation of the autophagic substrate SQSTM1 (Figure S6C), and autophagic flux (Fig. S6D). These data demonstrate that MAPK8-deficiency and MAPK9-deficiency (Fig. S6) cause no major defects in starvation-induced autophagy.

Requirement of MAPK8/9 for starvation-induced autophagy in primary epithelial cells {#S0002-S2006}
-----------------------------------------------------------------------------------

Our analysis of primary and immortalized MEFs suggests that MAPK8/9 play no required role in starvation-induced autophagy ([Figures 2](#F0002) and [4](#F0004)). However, studies of a different cell type may lead to a different conclusion. We therefore examined starvation-induced autophagic flux in primary kidney epithelial cells. We found that MAPK8/9 deficiency caused no difference in autophagic flux in these epithelial cells (Fig. S7A) and no difference in the accumulation of the autophagic substrate SQSTM1 (Fig. S7B) in response to starvation. These data demonstrate that MAPK8/9 have no required role in primary kidney epithelial cells for starvation-induced autophagy.

Requirement of MAPK8/9 for autophagy in response to Ras and hypoxia {#S0002-S2007}
-------------------------------------------------------------------

If MAPK8/9 are not required for autophagy in response to starvation or MTOR inhibition, it is possible that MAPK8/9 may be required for autophagy in response to other stimuli. We therefore examined control *trp53^−/-^* MEFs (-Ras) and *Hras* (Harvey rat sarcoma virus oncogene)-transformed (+ Ras) *trp53^−/-^* MEFs without (WT) and with ablation of the *Mapk8* and *Mapk9* genes (Fig. S8A). Autophagic flux studies demonstrated no significant effects of MAPK8/9 deficiency (Fig. S8B). These data indicate that MAPK8/9 are not required for autophagy in control or *Hras*-transformed *trp53^−/-^* MEFs.

We also studied control and *Hras*-transformed *trp53^−/-^* MEFs without (WT) and with ablation of the *Mapk8* and *Mapk9* genes under hypoxia (1.5% O~2~) conditions (Fig. S9A). Autophagic flux studies demonstrated no significant effects of MAPK8/9 deficiency (Fig. S9B). These data indicate that MAPK8/9 are not required for autophagy in control or *Hras*-transformed *trp53^−/-^* MEFs under hypoxia conditions.

MAPK8/9-regulated autophagy in primary hepatocytes {#S0002-S2008}
--------------------------------------------------

Autophagy plays a major role in systemic metabolic homeostasis \[[39](#CIT0039)\] and hepatic lipid metabolism \[[40](#CIT0040)\]. Moreover, hepatocytes have been reported to exhibit MAPK8/9-dependent autophagy \[[6](#CIT0006)\]. We therefore examined the requirement of MAPK8/9 for autophagy using primary hepatocytes prepared from *Albumin-Cre^−/+^* (*Alb-Cre^−/+^*) control mice and *Alb-cre^−/+^ Mapk8^LoxP/LoxP^ Mapk9^LoxP/LoxP^* mice. We found that MAPK8/9-deficient hepatocytes exhibited increased accumulation of LC3B-II following lysosomal inhibition and the reduced accumulation of the autophagic substrate SQSTM1 in MAPK8/9-deficient hepatocytes compared with control hepatocytes (Figure 5(a,b), S10A and B). These observations suggest that MAPK8/9 may inhibit autophagy in hepatocytes.

To confirm the conclusion that MAPK8/9 suppresses autophagic flux in primary hepatocytes, we examined wild-type (WT) hepatocytes treated with JNK-IN-8, a potent and selective small molecule inhibitor of MAPK8/9 \[[41](#CIT0041)\]. We found that treatment with JNK-IN-8 caused increased accumulation of LC3B-II following lysosomal inhibition ([Figure. 5(c)](#F0005) and S10C) and reduced accumulation of the autophagic substrate SQSTM1 ([Figure. 5(d)](#F0005) and S10D). These data indicate that pharmacological inhibition of MAPK8/9 causes increased autophagic flux.10.1080/15548627.2018.1466013-F0005Figure 5.MAPK8/9 suppresses autophagy in primary hepatocytes. (a) LC3B and TUBA in WT and *mapk8^−/-^ mapk9^−/-^* primary hepatocytes after incubation (6 h) with medium or EBSS containing 5 mM glucose in the presence or absence of 25 µM chloroquine (CQ) was examined by immunoblot analysis. (b) The amount of SQSTM1 and TUBA in WT and *mapk8^−/-^ mapk9^−/-^* primary hepatocytes was examined by immunoblot analysis. (c and d) WT primary hepatocytes were incubated (6 h) without or with 2 µM JNK-IN-8. LC3B and TUBA in WT primary hepatocytes in the presence or absence of 25 µM CQ was examined by immunoblot analysis (c). The amount of SQSTM1 and TUBA was examined by immunoblot analysis (d).

The increased autophagy caused by MAPK8/9 loss-of-function in hepatocytes compared with WT hepatocytes was unexpected. This increased autophagy may reflect the established role of MAPK8/9 to strongly suppress the transcriptional activity of the PPARA (peroxisome proliferator activated receptor alpha) nuclear receptor \[[42](#CIT0042)\] that can promote autophagy through increased expression of autophagic genes \[[43](#CIT0043)\]. This role of MAPK8/9 to suppress basal autophagy in hepatocytes is similar to the established function of MAPK8, MAPK9, and MAPK10/JNK3 (mitogen-activated protein kinase 10) in neurons to suppress basal autophagy by repression of autophagic gene expression \[[27](#CIT0027)\].

Discussion {#S0003}
==========

Studies of the genetically tractable organism *Drosophila melanogaster* demonstrate that the *basket* gene, which encodes a MAPK8/9 ortholog, can increase autophagy \[[44](#CIT0044)\]. It is established that Basket in *Drosophila* promotes autophagy by causing increased expression of autophagy proteins \[[44](#CIT0044)\]. This mechanism is also found in mammals \[[45](#CIT0045)--[51](#CIT0051)\]. Thus, MAPK8/9 may promote autophagy by increasing the expression of ATG4 (autophagy related 4) \[[49](#CIT0049)\], ATG5 \[[45](#CIT0045)\], BECN1 \[[48](#CIT0048)\], BNIP3 (BCL2/adenovirus E1B interacting protein 3) \[[47](#CIT0047),[50](#CIT0050)\], LC3B \[[46](#CIT0046),[51](#CIT0051)\], and SQSTM1 \[[46](#CIT0046)\]. MAPK8/9-regulated gene expression therefore represents an evolutionarily conserved mechanism of autophagic regulation. The specific physiological effects of MAPK8/9 on the expression of autophagic proteins likely reflects the combinatorial actions of MAPK8/9-regulated transcription factors together with other transcription factors that are activated by different signal transduction pathways. MAPK8/9 may therefore play an essential role in mammalian autophagy in some specific physiological or pathological contexts.

Recently, MAPK8 was proposed to promote starvation-induced autophagy in MEFs by a non-transcriptional mechanism \[[5](#CIT0005)\]. It was reported that *mapk8^−/-^* MEFs, but not *mapk9^−/-^* MEFs, are resistant to starvation-induced autophagy \[[5](#CIT0005)\]. The proposed mechanism was mediated by phosphorylation of BCL2 on Thr69, Ser70, and Ser87 by MAPK8, disruption of BCL2-BECN1 complexes, and the initiation of BECN1-dependent autophagy \[[5](#CIT0005)\]. This mechanism implies that MAPK8 is essential for BCL2 phosphorylation \[[5](#CIT0005)\]. However, other studies indicate that MAPK8 may only serve a redundant role in BCL2 phosphorylation \[[20](#CIT0020),[30](#CIT0030)--[34](#CIT0034)\]. The essential non-transcriptional role of MAPK8 in starvation-induced autophagy \[[5](#CIT0005)\] is therefore likely to be mediated by BCL2 phosphorylation only in specific cellular contexts.

Possible roles of MAPK8 in starvation-induced autophagy include functional interactions with TORC1, a master regulator of starvation-induced autophagy \[[4](#CIT0004)\]. Indeed, previous studies have demonstrated that MAPK8/9 can be activated in response to TORC1 signaling \[[35](#CIT0035)\] and that TORC1 activation can require MAPK8/9 signaling \[[28](#CIT0028)\]. However, we found no requirement for MAPK8/9 upstream ([Figure 1](#F0001)) or downstream ([Figure 2](#F0002)) of TORC1 during starvation-induced autophagy. The essential function of MAPK8/9 must therefore play a role in a pathway that is parallel to TORC1. These observations led us to test whether MAPK8/9 is required for starvation-induced autophagy. Our analysis demonstrates that MAPK8/9 is not required for starvation-induced autophagy in mouse fibroblasts or epithelial cells ([Figure. 2](#F0002) and S7).

Many reported studies support the conclusion that MAPK8/9 plays an essential role in the promotion of autophagy \[[5](#CIT0005)--[23](#CIT0023)\]. In contrast, our analysis does not indicate a major role for MAPK8/9 in starvation-induced autophagy. It is likely that small differences in cell culture conditions and starvation conditions may contribute to discrepancies between our analysis ([Figure 2](#F0002)) and previously published reports of the role of MAPK8/9 in MEFs \[[5](#CIT0005)\]. The use of the small molecule SP600125, that inhibits MAPK8/9 and many other protein kinases \[[52](#CIT0052)\], to draw conclusions concerning the specific role of MAPK8/9 may also contribute to conclusions \[[8](#CIT0008),[10](#CIT0010),[12](#CIT0012)--[19](#CIT0019),[22](#CIT0022),[51](#CIT0051)\] that contrast with those drawn from our analysis of MAPK8/9 knockout cells. Finally, some studies that have identified a role for MAPK8/9 do not focus on starvation-induced autophagy. One example is the requirement of MAPK8/9 for oncolytic adenovirus-mediated autophagy \[[20](#CIT0020)\]. Clearly our conclusions concerning the lack of a major role for MAPK8/9 in autophagy are restricted to the starvation, transformation, and hypoxia paradigms that we studied. Moreover, it should be noted that we found that starvation or an MTOR inhibitor under the conditions of our autophagy assays did not lead to MAPK8/9 activation. It is therefore possible that in a different cell type, or under different culture conditions, MAPK8/9 could be activated and thus may contribute to the regulation of autophagy.

In conclusion, our analysis demonstrates that there is no required role for MAPK8/9 in starvation-induced autophagy. However, this signaling pathway can regulate autophagy by a conserved mechanism that leads to regulated expression of autophagy proteins in *Drosophila* \[[44](#CIT0044)\] and mammals \[[45](#CIT0045)--[51](#CIT0051)\]. MAPK8/9-regulated gene expression may lead to increased autophagy, but different paradigms of MAPK8/9-regulated gene expression could lead to reduced autophagy. For example, MAPK8/9-regulated gene expression suppresses basal autophagy in neurons \[[27](#CIT0027)\]. A similar mechanism may account for MAPK8/9-mediated repression of autophagy in hepatocytes ([Figure 5](#F0005)). It is also possible that MAPK8/9 may promote autophagy by a non-transcriptional mechanism mediated by BCL2 phosphorylation in some specific physiological or pathological conditions. Collectively, our analysis shows that the role of MAPK8/9 in autophagy may be context-dependent and substantially more complex than previously considered.

Materials and methods {#S0004}
=====================

Cell culture {#S0004-S2001}
------------

Primary MEFs were prepared from embryonic day 13.5 WT, *mapk8^−/-^, mapk9^−/-^, Rosa-Cre^ERT^* and *Rosa-Cre^ERT^ Mapk8^LoxP/LoxP^ mapk9^−/-^* mice and cultured in Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific, 11,960,077) supplemented with 10% bovine growth serum (BGS; Thermo Fisher Scientific, SH30541.03), 1% penicillin/streptomycin (Thermo Fisher Scientific, 15,140,122) plus 1% L-glutamine (Thermo Fisher Scientific, 25,030,081) \[[53](#CIT0053)\]. *Cre^ERT^* primary MEFs were treated (24 h) with 1 µM (Z)-4-hydroxytamoxifen (Millipore Sigma, H7904) in culture media at passage \#1. Autophagy experiments were conducted on MEFs between passages \#2 and \#3.

Immortalized WT and *mapk8^−/-^ mapk9^−/-^* MEFs have been described previously \[[54](#CIT0054)\]. We have also previously described *trp53^−/-^* MEFs, *trp53^−/-^ mapk8^−/-^ mapk9^−/-^* MEFs, *Hras*-transformed *trp53^−/-^* MEFs, and *Hras* transformed *trp53^−/-^ mapk8^−/-^ mapk9^−/-^* MEFs \[[55](#CIT0055)\]. These cells were cultured in DMEM supplemented with 10% BGS, 1% penicillin/streptomycin, plus 1% L-glutamine.

Primary kidney epithelial cells were isolated from *ROSA-Cre^ERT^* mice or *ROSA-Cre^ERT^ Mapk8^LoxP/LoxP^ mapk9^−/-^* mice. Kidneys were digested (2 h) with 0.1% collagenase A (Millipore Sigma, 11,088,793,001) plus 0.1% trypsin (Thermo Fisher Scientific, 15,090,046) in DMEM with 150 mM NaCl \[[56](#CIT0056)\]. The cells were maintained in DMEM/F-12 media (Thermo Fisher Scientific, 11,039--047) containing 10% BGS, plus 150 mM urea and 150 mM NaCl. The cells were treated (24 h) with 1 µM (Z)-4-hydroxytamoxifen and employed for autophagy studies after 3 d.

Primary hepatocytes were isolated from WT (*Alb-Cre*^−/+^) and MAPK8/9-deficient (*Alb-Cre*^−/+^ *Mapk8^LoxP/LoxP^ Mapk9^LoxP/LoxP^*) mice \[[42](#CIT0042)\] using a modified 2-step perfusion method \[[57](#CIT0057)\] with Hanks' Balanced Salt Solution (HBSS; Thermo Fisher Scientific, 14,175) and Liver Digest Medium (Thermo Fisher Scientific, 17,703,034). Cells were seeded on plates pre-coated (1 h) with collagen I (Thermo Fisher Scientific, A1048301) in DMEM supplemented with 10% BGS, 2 mM sodium pyruvate (Thermo Fisher, 11,360,070), 1 μM dexamethasone (Millipore Sigma, D4902), 100 nM insulin (Millipore Sigma, I0516) plus 2% penicillin/streptomycin. After attachment (2 h), the medium was removed and the hepatocytes were incubated (22 h) in maintenance medium (DMEM (4.5 g/L glucose) supplemented with 10% BGS, 0.2% bovine serum albumin (Millipore Sigma, A8806), 2 mM sodium pyruvate, 2% penicillin/streptomycin, 0.1 μM dexamethasone, and 1 nM insulin. Autophagy studies were performed within 48 h. Pharmacological studies of MAPK8/9 inhibition were performed by treating hepatocytes with 2 µM JNK-IN-8 (Millipore Sigma, 420,150) or dimethyl sulfoxide (DMSO; Millipore Sigma, D2650).

Autophagy studies {#S0004-S2002}
-----------------

Autophagy promoted by amino acid starvation was examined using cells (70% confluent) washed 3 times with modified Earle's Balanced Salt Solution (EBSS; 117.24 mM NaCl, 26.19 mM NaHCO~3~, 5.33 mM KCl, 0.816 mM MgCl~2~, 1.01 mM NaH~2~PO~4~, 1.8 mM CaCl~2~, 10.92 mM HEPES, pH 7.4, 0.224 mM sodium pyruvate) and then incubated with EBSS containing 5 mM glucose. Autophagy was also examined in cells treated with pharmacological inhibitors of MTOR (250 nM torin 1; Tocris, 4247) and TORC1 (200 nM rapamycin; Millipore Sigma, R8781) or under hypoxia (1.5% O~2~) conditions. Autophagic flux was examined by measuring the LC3B-II:GAPDH ratio or LC3B-II:TUBA (tubulin alpha) ratio by immunoblot analysis, normalization of the data to the control condition (without autophagy induction or CQ), and calculation of the increased LC3B-II:GAPDH (or TUBA) ratio caused by treatment of the cells with 25 µM chloroquine diphosphate (CQ; Millipore Sigma, 25,745) to inhibit lysosomal protein degradation \[[36](#CIT0036)\].

Immunoblot analysis {#S0004-S2003}
-------------------

Cell extracts were prepared using Triton lysis buffer (20 mM Tris at pH 7.4, 1% Triton X-100 \[Millipore Sigma, X100\], 10% glycerol \[Millipore Sigma, G7793\], 137 mM NaCl, 2 mM EDTA \[Millipore Sigma, EDS\], 25 mM β-glycerophosphate \[Millipore Sigma, G9422\], 1 mM sodium orthovanadate \[Millipore Sigma, S6508\], 1 mM phenylmethylsulfonyl fluoride \[Millipore Sigma, P7626\], 10 µg/mL aprotinin \[Millipore Sigma, A6106\] plus leupeptin \[Millipore Sigma, L2884\]). Extracts (20--40 μg of protein) were examined by protein immunoblot analysis by probing with antibodies described in antibodies section. Immunocomplexes were detected using IRDye-conjugated secondary antibodies to mouse IgG (LI-COR Biosciences, 925--68,070) and rabbit IgG (LICOR Biosciences, 925--32,211) and quantified by using the Odyssey infrared imaging system (LI-COR Biosciences).

Antibodies {#S0004-S2004}
----------

We obtained antibodies to AKT (Cell Signaling Technology, 9272), p-Thr308 AKT (Cell Signaling Technology, 5106), p-Ser473 AKT (Cell Signaling Technology, 9271), GAPDH (Santa Cruz Biotechnology, sc-25,778), LC3B (Cell Signaling Technology, 2775), MAPK8/9 (R&D Systems, AF1387), p-Thr183/Tyr185 MAPK8/9 (Cell Signaling Technology, 9255 \[[Figure 3](#F0003)\] and Cell Signaling Technology, 4668 \[Figs. S8 and S9\]), RPS6KB1 (Cell Signaling Technology, 9202), p-Thr389 RPS6KB1 (Cell Signaling Technology, 9206), SQSTM1 (Progen, GP62-C), and TUBA (Millipore Sigma, T5168), from the indicated suppliers.

LC3B puncta formation {#S0004-S2005}
---------------------

Cells were transduced with a lentiviral vector that expresses GFP-LC3B according to the manufacturer's instructions (LentiBrite GFP-LC3 Lentiviral Biosensor; Millipore Sigma, 17--10,193). The cells were plated on a glass culture dish and incubated with culture media, EBSS containing 5mM glucose, or culture media supplemented with 250 nM torin 1. Live cell images were acquired at 0, 2, and 4 h using Leica TCS SP2 confocal microscope and Leica Confocal Software.

Statistical analysis {#S0004-S2006}
--------------------

Data are presented as the mean and standard error (SEM). Statistical analysis was performed using two-tailed Student's *t*-test for pair-wise comparisons and two-way ANOVA for multiple group comparisons as indicated at the figure legends.
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